IκB kinase beta–NF-κB essential modulator interface (IKKβ–NEMO interface)

The **IκB kinase beta–NF-κB essential modulator interface** (IKKβ–NEMO interface) is a crucial protein–protein interaction within the IκB kinase (IKK) complex, which is a key regulator of the canonical NF-κB signaling pathway. NEMO (also known as IKKγ) acts as a regulatory scaffolding protein that binds IKKβ at a defined region (the NEMO-binding domain, NBD, in IKKβ and the IKK-binding domain, KBD, in NEMO) to facilitate the formation and stability of the IKK complex[1][3][5][6]. This interaction enables phosphorylation and subsequent degradation of IκB proteins, leading to NF-κB activation and nuclear translocation—critical for inflammatory, immune, and cell survival responses[2][3]. Disruption of the IKKβ–NEMO interface blocks NF-κB activation and has shown therapeutic potential in models of cancer, chronic inflammation, muscular dystrophy, and other diseases driven by NF-κB dysregulation[4][5][6]. Both peptide and small molecule inhibitors targeting this interface have been studied, though therapeutic translation may be limited by risks of immunosuppression due to systemic NF-κB inhibition[4][5]. The molecular interface is characterized structurally as a four-helix bundle formed by the NEMO dimer and the C-terminal NBD of IKKβ, with critical hotspot residues facilitating the binding and function of the complex[1][5].

Other names

IKKβ–NEMO complexIKKβ–IKKγ interfaceIκB kinase beta–NF-κB essential modulator binding siteNEMO–IKKβ interactionNEMO binding domain (in IKKβ or NEMO context)

Inhibition of complex formation between IKKβ and NEMO to prevent activation of the canonical NF-κB pathway